| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.1 |